Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F5SLJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,213
Award facts
- Contract value 100% obligated
- $43,213.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on June 25, 2026, for Dupixent 300 mg/2 ml pen injections with a ceiling value of $43,213.22 under a firm fixed-price award.
Place of performance is Conshohocken, PA. The order ultimate completion date is June 26, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on a full and open basis without set-asides.
Quick answers
Who was awarded contract SPE2DR26F5SLJ?
SPE2DR26F5SLJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2026.
How much is contract SPE2DR26F5SLJ worth?
The government has obligated $43,213 on SPE2DR26F5SLJ.
Is contract SPE2DR26F5SLJ an order under another contract?
Yes. SPE2DR26F5SLJ is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5SLJ competed?
The extent of competition for SPE2DR26F5SLJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award